Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Cerilliant
Chinese Patent Office
Medtronic
Chubb
Daiichi Sankyo
Mallinckrodt
Dow
McKinsey

Generated: February 19, 2018

DrugPatentWatch Database Preview

SANCTURA XR Drug Profile

« Back to Dashboard

Which patents cover Sanctura Xr, and when can generic versions of Sanctura Xr launch?

Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has fifteen patent family members in eleven countries.

The generic ingredient in SANCTURA XR is trospium chloride. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
Summary for SANCTURA XR
International Patents:15
US Patents:5
Applicants:1
NDAs:1
Bulk Api Vendors: 71
Clinical Trials: 5
Patent Applications: 1,382
Drug Prices:see details
DailyMed Link:SANCTURA XR at DailyMed
Drug patent expirations by year for SANCTURA XR

US Patents and Regulatory Information for SANCTURA XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SANCTURA XR
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Capsules 60 mg ➤ Subscribe 3/2/2009

Premature patent expiration for: SANCTURA XR

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
➤ Sign Up SANCTURA XR ➤ Sign Up

International Patents for SANCTURA XR

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Merck
UBS
Colorcon
Federal Trade Commission
McKinsey
Julphar
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot